Compensated Cirrhosis Type C Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Compensated Cirrhosis Type C Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Antagonist
        1.2.3 Antiviral Drugs
        1.2.4 Corticosteroids
        1.2.5 Chelating Agents
    1.3 Market by Application
        1.3.1 Global Compensated Cirrhosis Type C Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Retail Pharmacy
        1.3.3 Hospital Pharmacy
        1.3.4 Online Pharmacy
        1.3.5 Drug Store
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Compensated Cirrhosis Type C Market Perspective (2017-2028)
    2.2 Compensated Cirrhosis Type C Growth Trends by Region
        2.2.1 Compensated Cirrhosis Type C Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Compensated Cirrhosis Type C Historic Market Size by Region (2017-2022)
        2.2.3 Compensated Cirrhosis Type C Forecasted Market Size by Region (2023-2028)
    2.3 Compensated Cirrhosis Type C Market Dynamics
        2.3.1 Compensated Cirrhosis Type C Industry Trends
        2.3.2 Compensated Cirrhosis Type C Market Drivers
        2.3.3 Compensated Cirrhosis Type C Market Challenges
        2.3.4 Compensated Cirrhosis Type C Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Compensated Cirrhosis Type C Players by Revenue
        3.1.1 Global Top Compensated Cirrhosis Type C Players by Revenue (2017-2022)
        3.1.2 Global Compensated Cirrhosis Type C Revenue Market Share by Players (2017-2022)
    3.2 Global Compensated Cirrhosis Type C Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Compensated Cirrhosis Type C Revenue
    3.4 Global Compensated Cirrhosis Type C Market Concentration Ratio
        3.4.1 Global Compensated Cirrhosis Type C Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Compensated Cirrhosis Type C Revenue in 2021
    3.5 Compensated Cirrhosis Type C Key Players Head office and Area Served
    3.6 Key Players Compensated Cirrhosis Type C Product Solution and Service
    3.7 Date of Enter into Compensated Cirrhosis Type C Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Compensated Cirrhosis Type C Breakdown Data by Type
    4.1 Global Compensated Cirrhosis Type C Historic Market Size by Type (2017-2022)
    4.2 Global Compensated Cirrhosis Type C Forecasted Market Size by Type (2023-2028)
5 Compensated Cirrhosis Type C Breakdown Data by Application
    5.1 Global Compensated Cirrhosis Type C Historic Market Size by Application (2017-2022)
    5.2 Global Compensated Cirrhosis Type C Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Compensated Cirrhosis Type C Market Size (2017-2028)
    6.2 North America Compensated Cirrhosis Type C Market Size by Type
        6.2.1 North America Compensated Cirrhosis Type C Market Size by Type (2017-2022)
        6.2.2 North America Compensated Cirrhosis Type C Market Size by Type (2023-2028)
        6.2.3 North America Compensated Cirrhosis Type C Market Share by Type (2017-2028)
    6.3 North America Compensated Cirrhosis Type C Market Size by Application
        6.3.1 North America Compensated Cirrhosis Type C Market Size by Application (2017-2022)
        6.3.2 North America Compensated Cirrhosis Type C Market Size by Application (2023-2028)
        6.3.3 North America Compensated Cirrhosis Type C Market Share by Application (2017-2028)
    6.4 North America Compensated Cirrhosis Type C Market Size by Country
        6.4.1 North America Compensated Cirrhosis Type C Market Size by Country (2017-2022)
        6.4.2 North America Compensated Cirrhosis Type C Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Compensated Cirrhosis Type C Market Size (2017-2028)
    7.2 Europe Compensated Cirrhosis Type C Market Size by Type
        7.2.1 Europe Compensated Cirrhosis Type C Market Size by Type (2017-2022)
        7.2.2 Europe Compensated Cirrhosis Type C Market Size by Type (2023-2028)
        7.2.3 Europe Compensated Cirrhosis Type C Market Share by Type (2017-2028)
    7.3 Europe Compensated Cirrhosis Type C Market Size by Application
        7.3.1 Europe Compensated Cirrhosis Type C Market Size by Application (2017-2022)
        7.3.2 Europe Compensated Cirrhosis Type C Market Size by Application (2023-2028)
        7.3.3 Europe Compensated Cirrhosis Type C Market Share by Application (2017-2028)
    7.4 Europe Compensated Cirrhosis Type C Market Size by Country
        7.4.1 Europe Compensated Cirrhosis Type C Market Size by Country (2017-2022)
        7.4.2 Europe Compensated Cirrhosis Type C Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Compensated Cirrhosis Type C Market Size (2017-2028)
    8.2 Asia-Pacific Compensated Cirrhosis Type C Market Size by Type
        8.2.1 Asia-Pacific Compensated Cirrhosis Type C Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Compensated Cirrhosis Type C Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Compensated Cirrhosis Type C Market Share by Type (2017-2028)
    8.3 Asia-Pacific Compensated Cirrhosis Type C Market Size by Application
        8.3.1 Asia-Pacific Compensated Cirrhosis Type C Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Compensated Cirrhosis Type C Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Compensated Cirrhosis Type C Market Share by Application (2017-2028)
    8.4 Asia-Pacific Compensated Cirrhosis Type C Market Size by Region
        8.4.1 Asia-Pacific Compensated Cirrhosis Type C Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Compensated Cirrhosis Type C Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Compensated Cirrhosis Type C Market Size (2017-2028)
    9.2 Latin America Compensated Cirrhosis Type C Market Size by Type
        9.2.1 Latin America Compensated Cirrhosis Type C Market Size by Type (2017-2022)
        9.2.2 Latin America Compensated Cirrhosis Type C Market Size by Type (2023-2028)
        9.2.3 Latin America Compensated Cirrhosis Type C Market Share by Type (2017-2028)
    9.3 Latin America Compensated Cirrhosis Type C Market Size by Application
        9.3.1 Latin America Compensated Cirrhosis Type C Market Size by Application (2017-2022)
        9.3.2 Latin America Compensated Cirrhosis Type C Market Size by Application (2023-2028)
        9.3.3 Latin America Compensated Cirrhosis Type C Market Share by Application (2017-2028)
    9.4 Latin America Compensated Cirrhosis Type C Market Size by Country
        9.4.1 Latin America Compensated Cirrhosis Type C Market Size by Country (2017-2022)
        9.4.2 Latin America Compensated Cirrhosis Type C Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Compensated Cirrhosis Type C Market Size (2017-2028)
    10.2 Middle East & Africa Compensated Cirrhosis Type C Market Size by Type
        10.2.1 Middle East & Africa Compensated Cirrhosis Type C Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Compensated Cirrhosis Type C Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Compensated Cirrhosis Type C Market Share by Type (2017-2028)
    10.3 Middle East & Africa Compensated Cirrhosis Type C Market Size by Application
        10.3.1 Middle East & Africa Compensated Cirrhosis Type C Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Compensated Cirrhosis Type C Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Compensated Cirrhosis Type C Market Share by Application (2017-2028)
    10.4 Middle East & Africa Compensated Cirrhosis Type C Market Size by Country
        10.4.1 Middle East & Africa Compensated Cirrhosis Type C Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Compensated Cirrhosis Type C Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Gilead Sciences, Inc.
        11.1.1 Gilead Sciences, Inc. Company Details
        11.1.2 Gilead Sciences, Inc. Business Overview
        11.1.3 Gilead Sciences, Inc. Compensated Cirrhosis Type C Introduction
        11.1.4 Gilead Sciences, Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.1.5 Gilead Sciences, Inc. Recent Developments
    11.2 AbbVie Inc.
        11.2.1 AbbVie Inc. Company Details
        11.2.2 AbbVie Inc. Business Overview
        11.2.3 AbbVie Inc. Compensated Cirrhosis Type C Introduction
        11.2.4 AbbVie Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.2.5 AbbVie Inc. Recent Developments
    11.3 Novartis International AG
        11.3.1 Novartis International AG Company Details
        11.3.2 Novartis International AG Business Overview
        11.3.3 Novartis International AG Compensated Cirrhosis Type C Introduction
        11.3.4 Novartis International AG Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.3.5 Novartis International AG Recent Developments
    11.4 Intercept Pharmaceuticals, Inc.
        11.4.1 Intercept Pharmaceuticals, Inc. Company Details
        11.4.2 Intercept Pharmaceuticals, Inc. Business Overview
        11.4.3 Intercept Pharmaceuticals, Inc. Compensated Cirrhosis Type C Introduction
        11.4.4 Intercept Pharmaceuticals, Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.4.5 Intercept Pharmaceuticals, Inc. Recent Developments
    11.5 Novo Nordisk A/S
        11.5.1 Novo Nordisk A/S Company Details
        11.5.2 Novo Nordisk A/S Business Overview
        11.5.3 Novo Nordisk A/S Compensated Cirrhosis Type C Introduction
        11.5.4 Novo Nordisk A/S Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.5.5 Novo Nordisk A/S Recent Developments
    11.6 Eli Lilly and Company
        11.6.1 Eli Lilly and Company Company Details
        11.6.2 Eli Lilly and Company Business Overview
        11.6.3 Eli Lilly and Company Compensated Cirrhosis Type C Introduction
        11.6.4 Eli Lilly and Company Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.6.5 Eli Lilly and Company Recent Developments
    11.7 Alnylam Pharmaceuticals Inc.
        11.7.1 Alnylam Pharmaceuticals Inc. Company Details
        11.7.2 Alnylam Pharmaceuticals Inc. Business Overview
        11.7.3 Alnylam Pharmaceuticals Inc. Compensated Cirrhosis Type C Introduction
        11.7.4 Alnylam Pharmaceuticals Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.7.5 Alnylam Pharmaceuticals Inc. Recent Developments
    11.8 Cadila Healthcare Ltd
        11.8.1 Cadila Healthcare Ltd Company Details
        11.8.2 Cadila Healthcare Ltd Business Overview
        11.8.3 Cadila Healthcare Ltd Compensated Cirrhosis Type C Introduction
        11.8.4 Cadila Healthcare Ltd Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.8.5 Cadila Healthcare Ltd Recent Developments
    11.9 Sanofi S.A
        11.9.1 Sanofi S.A Company Details
        11.9.2 Sanofi S.A Business Overview
        11.9.3 Sanofi S.A Compensated Cirrhosis Type C Introduction
        11.9.4 Sanofi S.A Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.9.5 Sanofi S.A Recent Developments
    11.10 Pfizer Inc.
        11.10.1 Pfizer Inc. Company Details
        11.10.2 Pfizer Inc. Business Overview
        11.10.3 Pfizer Inc. Compensated Cirrhosis Type C Introduction
        11.10.4 Pfizer Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.10.5 Pfizer Inc. Recent Developments
    11.11 Sun Pharmaceutical Industries Limited
        11.11.1 Sun Pharmaceutical Industries Limited Company Details
        11.11.2 Sun Pharmaceutical Industries Limited Business Overview
        11.11.3 Sun Pharmaceutical Industries Limited Compensated Cirrhosis Type C Introduction
        11.11.4 Sun Pharmaceutical Industries Limited Revenue in Compensated Cirrhosis Type C Business (2017-2022)
        11.11.5 Sun Pharmaceutical Industries Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Compensated Cirrhosis Type C Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Antagonist
    Table 3. Key Players of Antiviral Drugs
    Table 4. Key Players of Corticosteroids
    Table 5. Key Players of Chelating Agents
    Table 6. Global Compensated Cirrhosis Type C Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Compensated Cirrhosis Type C Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Compensated Cirrhosis Type C Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Compensated Cirrhosis Type C Market Share by Region (2017-2022)
    Table 10. Global Compensated Cirrhosis Type C Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Compensated Cirrhosis Type C Market Share by Region (2023-2028)
    Table 12. Compensated Cirrhosis Type C Market Trends
    Table 13. Compensated Cirrhosis Type C Market Drivers
    Table 14. Compensated Cirrhosis Type C Market Challenges
    Table 15. Compensated Cirrhosis Type C Market Restraints
    Table 16. Global Compensated Cirrhosis Type C Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Compensated Cirrhosis Type C Revenue Share by Players (2017-2022)
    Table 18. Global Top Compensated Cirrhosis Type C by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compensated Cirrhosis Type C as of 2021)
    Table 19. Ranking of Global Top Compensated Cirrhosis Type C Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Compensated Cirrhosis Type C Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Compensated Cirrhosis Type C Product Solution and Service
    Table 23. Date of Enter into Compensated Cirrhosis Type C Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Compensated Cirrhosis Type C Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Compensated Cirrhosis Type C Revenue Market Share by Type (2017-2022)
    Table 27. Global Compensated Cirrhosis Type C Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Compensated Cirrhosis Type C Revenue Market Share by Type (2023-2028)
    Table 29. Global Compensated Cirrhosis Type C Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Compensated Cirrhosis Type C Revenue Share by Application (2017-2022)
    Table 31. Global Compensated Cirrhosis Type C Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Compensated Cirrhosis Type C Revenue Share by Application (2023-2028)
    Table 33. North America Compensated Cirrhosis Type C Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Compensated Cirrhosis Type C Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Compensated Cirrhosis Type C Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Compensated Cirrhosis Type C Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Compensated Cirrhosis Type C Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Compensated Cirrhosis Type C Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Compensated Cirrhosis Type C Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Compensated Cirrhosis Type C Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Compensated Cirrhosis Type C Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Compensated Cirrhosis Type C Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Compensated Cirrhosis Type C Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Compensated Cirrhosis Type C Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Compensated Cirrhosis Type C Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Compensated Cirrhosis Type C Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Compensated Cirrhosis Type C Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Compensated Cirrhosis Type C Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Compensated Cirrhosis Type C Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Compensated Cirrhosis Type C Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Compensated Cirrhosis Type C Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Compensated Cirrhosis Type C Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Compensated Cirrhosis Type C Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Compensated Cirrhosis Type C Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Compensated Cirrhosis Type C Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Compensated Cirrhosis Type C Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Compensated Cirrhosis Type C Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Compensated Cirrhosis Type C Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Compensated Cirrhosis Type C Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Compensated Cirrhosis Type C Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Compensated Cirrhosis Type C Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Compensated Cirrhosis Type C Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Gilead Sciences, Inc. Company Details
    Table 64. Gilead Sciences, Inc. Business Overview
    Table 65. Gilead Sciences, Inc. Compensated Cirrhosis Type C Product
    Table 66. Gilead Sciences, Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 67. Gilead Sciences, Inc. Recent Developments
    Table 68. AbbVie Inc. Company Details
    Table 69. AbbVie Inc. Business Overview
    Table 70. AbbVie Inc. Compensated Cirrhosis Type C Product
    Table 71. AbbVie Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 72. AbbVie Inc. Recent Developments
    Table 73. Novartis International AG Company Details
    Table 74. Novartis International AG Business Overview
    Table 75. Novartis International AG Compensated Cirrhosis Type C Product
    Table 76. Novartis International AG Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 77. Novartis International AG Recent Developments
    Table 78. Intercept Pharmaceuticals, Inc. Company Details
    Table 79. Intercept Pharmaceuticals, Inc. Business Overview
    Table 80. Intercept Pharmaceuticals, Inc. Compensated Cirrhosis Type C Product
    Table 81. Intercept Pharmaceuticals, Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 82. Intercept Pharmaceuticals, Inc. Recent Developments
    Table 83. Novo Nordisk A/S Company Details
    Table 84. Novo Nordisk A/S Business Overview
    Table 85. Novo Nordisk A/S Compensated Cirrhosis Type C Product
    Table 86. Novo Nordisk A/S Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 87. Novo Nordisk A/S Recent Developments
    Table 88. Eli Lilly and Company Company Details
    Table 89. Eli Lilly and Company Business Overview
    Table 90. Eli Lilly and Company Compensated Cirrhosis Type C Product
    Table 91. Eli Lilly and Company Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 92. Eli Lilly and Company Recent Developments
    Table 93. Alnylam Pharmaceuticals Inc. Company Details
    Table 94. Alnylam Pharmaceuticals Inc. Business Overview
    Table 95. Alnylam Pharmaceuticals Inc. Compensated Cirrhosis Type C Product
    Table 96. Alnylam Pharmaceuticals Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 97. Alnylam Pharmaceuticals Inc. Recent Developments
    Table 98. Cadila Healthcare Ltd Company Details
    Table 99. Cadila Healthcare Ltd Business Overview
    Table 100. Cadila Healthcare Ltd Compensated Cirrhosis Type C Product
    Table 101. Cadila Healthcare Ltd Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 102. Cadila Healthcare Ltd Recent Developments
    Table 103. Sanofi S.A Company Details
    Table 104. Sanofi S.A Business Overview
    Table 105. Sanofi S.A Compensated Cirrhosis Type C Product
    Table 106. Sanofi S.A Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 107. Sanofi S.A Recent Developments
    Table 108. Pfizer Inc. Company Details
    Table 109. Pfizer Inc. Business Overview
    Table 110. Pfizer Inc. Compensated Cirrhosis Type C Product
    Table 111. Pfizer Inc. Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 112. Pfizer Inc. Recent Developments
    Table 113. Sun Pharmaceutical Industries Limited Company Details
    Table 114. Sun Pharmaceutical Industries Limited Business Overview
    Table 115. Sun Pharmaceutical Industries Limited Compensated Cirrhosis Type C Product
    Table 116. Sun Pharmaceutical Industries Limited Revenue in Compensated Cirrhosis Type C Business (2017-2022) & (US$ Million)
    Table 117. Sun Pharmaceutical Industries Limited Recent Developments
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Compensated Cirrhosis Type C Market Share by Type: 2021 VS 2028
    Figure 2. Antagonist Features
    Figure 3. Antiviral Drugs Features
    Figure 4. Corticosteroids Features
    Figure 5. Chelating Agents Features
    Figure 6. Global Compensated Cirrhosis Type C Market Share by Application: 2021 VS 2028
    Figure 7. Retail Pharmacy Case Studies
    Figure 8. Hospital Pharmacy Case Studies
    Figure 9. Online Pharmacy Case Studies
    Figure 10. Drug Store Case Studies
    Figure 11. Compensated Cirrhosis Type C Report Years Considered
    Figure 12. Global Compensated Cirrhosis Type C Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Compensated Cirrhosis Type C Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Compensated Cirrhosis Type C Market Share by Region: 2021 VS 2028
    Figure 15. Global Compensated Cirrhosis Type C Market Share by Players in 2021
    Figure 16. Global Top Compensated Cirrhosis Type C Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compensated Cirrhosis Type C as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Compensated Cirrhosis Type C Revenue in 2021
    Figure 18. North America Compensated Cirrhosis Type C Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Compensated Cirrhosis Type C Market Size Market Share by Type (2017-2028)
    Figure 20. North America Compensated Cirrhosis Type C Market Size Market Share by Application (2017-2028)
    Figure 21. North America Compensated Cirrhosis Type C Market Size Share by Country (2017-2028)
    Figure 22. United States Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Compensated Cirrhosis Type C Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Compensated Cirrhosis Type C Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Compensated Cirrhosis Type C Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Compensated Cirrhosis Type C Market Size Share by Country (2017-2028)
    Figure 28. Germany Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Compensated Cirrhosis Type C Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Compensated Cirrhosis Type C Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Compensated Cirrhosis Type C Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Compensated Cirrhosis Type C Market Size Share by Region (2017-2028)
    Figure 38. China Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Compensated Cirrhosis Type C Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Compensated Cirrhosis Type C Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Compensated Cirrhosis Type C Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Compensated Cirrhosis Type C Market Size Share by Country (2017-2028)
    Figure 48. Mexico Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Compensated Cirrhosis Type C Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Compensated Cirrhosis Type C Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Compensated Cirrhosis Type C Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Compensated Cirrhosis Type C Market Size Share by Country (2017-2028)
    Figure 54. Turkey Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Compensated Cirrhosis Type C Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Gilead Sciences, Inc. Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 58. AbbVie Inc. Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 59. Novartis International AG Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 60. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 61. Novo Nordisk A/S Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 62. Eli Lilly and Company Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 63. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 64. Cadila Healthcare Ltd Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 65. Sanofi S.A Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 66. Pfizer Inc. Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 67. Sun Pharmaceutical Industries Limited Revenue Growth Rate in Compensated Cirrhosis Type C Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed